7-150286516-C-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_001164458.2(ACTR3C):​c.322G>A​(p.Asp108Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000267 in 1,611,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D108H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000086 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

ACTR3C
NM_001164458.2 missense

Scores

1
6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.41

Publications

0 publications found
Variant links:
Genes affected
ACTR3C (HGNC:37282): (actin related protein 3C) Predicted to enable ATP binding activity. Predicted to contribute to actin filament binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3765816).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTR3CNM_001164458.2 linkc.322G>A p.Asp108Asn missense_variant Exon 5 of 8 ENST00000683684.1 NP_001157930.1 Q9C0K3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTR3CENST00000683684.1 linkc.322G>A p.Asp108Asn missense_variant Exon 5 of 8 NM_001164458.2 ENSP00000507618.1 Q9C0K3-1

Frequencies

GnomAD3 genomes
AF:
0.0000864
AC:
13
AN:
150458
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000744
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000659
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000598
AC:
15
AN:
250732
AF XY:
0.0000812
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000205
AC:
30
AN:
1460778
Hom.:
0
Cov.:
31
AF XY:
0.0000234
AC XY:
17
AN XY:
726588
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33274
American (AMR)
AF:
0.000246
AC:
11
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39678
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85782
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53338
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000899
AC:
10
AN:
1111820
Other (OTH)
AF:
0.00
AC:
0
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000864
AC:
13
AN:
150458
Hom.:
0
Cov.:
30
AF XY:
0.0000818
AC XY:
6
AN XY:
73366
show subpopulations
African (AFR)
AF:
0.0000744
AC:
3
AN:
40312
American (AMR)
AF:
0.000659
AC:
10
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4704
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67938
Other (OTH)
AF:
0.00
AC:
0
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000136
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 15, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.322G>A (p.D108N) alteration is located in exon 5 (coding exon 4) of the ACTR3C gene. This alteration results from a G to A substitution at nucleotide position 322, causing the aspartic acid (D) at amino acid position 108 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.55
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
.;T;.;.
Eigen
Uncertain
0.23
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.95
D;D;D;D
M_CAP
Benign
0.0019
T
MetaRNN
Benign
0.38
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.2
.;M;.;.
PhyloP100
4.4
PROVEAN
Pathogenic
-4.5
D;D;D;D
REVEL
Benign
0.17
Sift
Benign
0.097
T;D;D;D
Sift4G
Uncertain
0.048
D;T;T;.
Polyphen
0.99
.;D;.;.
Vest4
0.57, 0.63
MutPred
0.67
.;Loss of catalytic residue at D108 (P = 0.0362);Loss of catalytic residue at D108 (P = 0.0362);.;
MVP
0.26
MPC
0.40
ClinPred
0.80
D
GERP RS
2.5
Varity_R
0.41
gMVP
0.61
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780988364; hg19: chr7-149983605; API